V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20216037 | 20180739 | 1.67 | 40.3 | Palliative (P) | 2022-05-02 | 2022-05-21 | CISPLATIN + GEMCITABINE | 02 | N | CISPLATIN + GEMCITABINE | 101352165 |
| 20216067 | 20180741 | 1.59 | 65.4 | null | 2018-05-16 | 2018-07-10 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | null | CISPLATIN + GEMCITABINE | 100741522 |
| 20216074 | 20180742 | 1.72 | 60.7 | Palliative (P) | 2021-11-11 | 2021-11-18 | CISPLATIN + GEMCITABINE | 02 | null | CISPLATIN + GEMCITABINE | 101290405 |
| 20216094 | 20180743 | 1.61 | 68.9 | Palliative (P) | 2021-02-25 | 2021-02-25 | Capecitabine (21 day) + Irinotecan | 02 | N | CAPECITABINE + IRINOTECAN | 101138290 |
| 20216110 | 20180744 | 1.61 | 76 | Palliative (P) | 2017-10-29 | 2020-07-06 | CISPLATIN + GEMCITABINE | 2 | N | CISPLATIN + GEMCITABINE | 100655310 |
| 20216173 | 20180745 | 1.59 | 70 | Palliative (P) | 2019-09-21 | 2019-11-25 | CAPECITABINE + IRINOTECAN | 02 | N | CAPECITABINE + IRINOTECAN | 101823820 |
| 20216210 | 20180746 | 1.61 | 53.6 | Palliative (P) | null | 2022-05-13 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101660393 |
| 20216244 | 20180747 | 2 | 72.6 | Palliative (P) | 2019-08-08 | 2019-08-13 | CETUXIMAB + IRINOTECAN + MDG | N | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101755791 |
| 20216277 | 20180748 | 1.67 | 93.4 | null | 2016-08-28 | 2016-08-29 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | DOCETAXEL | 101139226 |
| 20216376 | 20180749 | 1.61 | 54 | Palliative (P) | 2021-11-17 | 2021-11-17 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101759653 |
| 20216401 | 20180750 | 1.54 | 56.5 | Palliative (P) | 2022-03-09 | 2022-03-15 | Docetaxel | 02 | N | DOCETAXEL | 100335388 |
| 20216410 | 20180751 | 1.65 | 96.4 | Adjuvant (A) | 2021-10-31 | 2021-11-24 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101170759 |
| 20216441 | 20180752 | 1.88 | 36 | Palliative (P) | 2022-01-12 | 2022-01-27 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101643539 |
| 20216482 | 20180753 | 1.7 | 79 | null | 2019-12-07 | 2020-01-06 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 100608251 |
| 20216538 | 20180754 | 1.68 | 79.7 | Palliative (P) | 2016-09-25 | 2017-02-14 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100368325 |
| 20216547 | 20180755 | 1.64 | 56 | Palliative (P) | 2019-03-14 | 2019-03-28 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100543523 |
| 20216557 | 20180756 | 1.89 | 75.8 | null | 2021-05-07 | 2021-05-23 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100582991 |
| 20216621 | 20180757 | 1.76 | 79.4 | Palliative (P) | 2021-06-30 | 2021-08-21 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101826216 |
| 20216640 | 20180758 | 1.54 | 80 | Neo-adjuvant (N) | 2018-01-02 | 2018-01-09 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101216275 |
| 20216662 | 20180759 | null | 62.2 | Palliative (P) | 2021-02-02 | 2021-06-03 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101184567 |
| 20216669 | 20180760 | 1.74 | 89 | null | 2020-07-28 | 2021-05-07 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101816080 |
| 20216722 | 20180761 | 1.74 | 88.6 | Palliative (P) | 2018-08-20 | 2018-09-20 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100987004 |
| 20216724 | 20180762 | 1.78 | 71.8 | Palliative (P) | null | 2017-04-09 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100546967 |
| 20216865 | 20180763 | 1.68 | 61.9 | Adjuvant (A) | 2017-04-05 | 2017-11-30 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101333133 |
| 20217106 | 20180764 | 1.83 | 56.5 | null | 2019-09-06 | 2019-09-20 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101305955 |
| 20217211 | 20180765 | 1.68 | 71.8 | Palliative (P) | 2016-09-30 | 2016-09-30 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100599443 |
| 20217333 | 20180766 | 1.65 | 56.6 | Palliative (P) | null | 2018-01-15 | Trastuzumab | N | N | TRASTUZUMAB | 100638633 |
| 20217455 | 20180768 | 1.56 | 81 | Palliative (P) | 2021-04-17 | 2021-04-17 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100146658 |
| 20217655 | 20180770 | 1.62 | 84.2 | null | 2022-02-21 | 2022-02-22 | Capecitabine + Cisplatin | N | null | CAPECITABINE + CISPLATIN | 101732104 |
| 20217781 | 20180771 | 1.74 | 77.9 | null | 2019-07-07 | 2019-07-18 | Capecitabine + Cisplatin + RT | 02 | null | CAPECITABINE + CISPLATIN | 100499828 |
| 20217934 | 20180772 | 1.65 | 104 | Palliative (P) | 2016-09-13 | 2016-10-05 | Trastuzumab 21 day maintenance | 02 | null | TRASTUZUMAB | 101174738 |
| 20217989 | 20180773 | 1.64 | 75 | null | 2018-01-07 | 2018-01-25 | Cetuximab 14 day | 02 | null | CETUXIMAB | 101038346 |
| 20217992 | 20180774 | 1.76 | 71 | Palliative (P) | 2019-06-29 | 2019-08-12 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101860127 |
| 20218010 | 20180775 | 1.77 | 82.6 | null | 2020-06-27 | 2020-07-03 | CETUXIMAB | 02 | null | CETUXIMAB | 100660882 |
| 20218111 | 20180776 | 1.7 | 65 | Neo-adjuvant (N) | null | 2017-04-19 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100856685 |
| 20218154 | 20180777 | 1.81 | 76.2 | null | 2017-07-09 | 2017-07-16 | CETUXIMAB | 02 | null | TRASTUZUMAB | 100750336 |
| 20218493 | 20180778 | 1.73 | null | Palliative (P) | 2019-04-08 | 2019-04-27 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100056429 |
| 20219015 | 20180780 | 1.7 | 68.3 | Curative (C) | 2018-09-14 | 2018-10-01 | Cetuximab 14 day | 02 | Y | TRASTUZUMAB | 100687325 |
| 20219051 | 20180781 | 1.52 | 93.2 | null | 2018-12-05 | 2019-01-08 | Trastuzumab 21 day maintenance | 02 | Y | TRASTUZUMAB | 101650398 |
| 20219081 | 20180782 | 1.62 | 54.2 | Neo-adjuvant (N) | 2018-11-28 | 2018-12-01 | Cetuximab 14 day | 02 | null | CAPECITABINE + CISPLATIN | 100398303 |
| 20219389 | 20180783 | 1.66 | 62.6 | Curative (C) | 2016-04-25 | 2016-07-11 | Cetuximab 14 day | 02 | N | TRASTUZUMAB | 100561204 |
| 20219485 | 20180784 | 1.73 | 83.9 | null | 2020-04-25 | 2020-05-10 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 101147109 |
| 20219732 | 20180785 | 1.73 | 46.6 | null | null | 2019-06-27 | CETUXIMAB | 02 | null | CETUXIMAB | 101424888 |
| 20220179 | 20180787 | 1.76 | 72 | null | 2019-05-09 | 2019-05-11 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 101150997 |
| 20220243 | 20180788 | 1.61 | 69.2 | Adjuvant (A) | 2017-06-04 | 2017-06-25 | CETUXIMAB | null | N | CAPECITABINE + CISPLATIN | 100340220 |
| 20220352 | 20180789 | 1.62 | 114 | Palliative (P) | 2018-08-30 | 2018-09-14 | CETUXIMAB | N | N | CETUXIMAB | 101225375 |
| 20220624 | 20180790 | 1.8 | 110.8 | null | 2020-01-26 | 2020-02-11 | Cetuximab 14 day | 02 | null | CAPECITABINE + CISPLATIN | 100526319 |
| 20220745 | 20180791 | 1.64 | 69.3 | Palliative (P) | 2019-04-17 | 2019-05-23 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100231340 |
| 20220747 | 20180792 | 1.65 | 61.9 | null | 2018-07-19 | 2018-11-11 | Trastuzumab 21 day maintenance | 02 | null | TRASTUZUMAB | 101606636 |
| 20220800 | 20180793 | 1.82 | 50 | null | 2019-12-13 | 2020-06-05 | Cetuximab 14 day | 02 | null | CETUXIMAB | 100941969 |